Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Obstructive Lung Diseases

  Free Subscription

Articles published in Curr Opin Pulm Med

Retrieve available abstracts of 23 articles:
HTML format

Single Articles

    November 2022
  1. O'NEILL E, Ryan S, McNicholas WT
    Chronic obstructive pulmonary disease and obstructive sleep apnoea overlap: co-existence, co-morbidity, or causality?
    Curr Opin Pulm Med. 2022;28:543-551.
    PubMed     Abstract available

    July 2022
  2. GARCIA AR, Piccari L
    Emerging phenotypes of pulmonary hypertension associated with COPD a field guide.
    Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00012.
    PubMed     Abstract available

  3. SPAGNOLO P, Semenzato U
    Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease).
    Curr Opin Pulm Med. 2022;28:296-302.
    PubMed     Abstract available

    May 2022
    Editorial: Advancements in asthma diagnosis and management: what's new?
    Curr Opin Pulm Med. 2022;28:232-233.

  5. NORRIS MR, Modi S, Al-Shaikhly T
    SMART - is it practical in the United States?
    Curr Opin Pulm Med. 2022;28:245-250.
    PubMed     Abstract available

    March 2022
  6. NAWAZ SF, Ravindran M, Kuruvilla ME
    Asthma diagnosis using patient-reported outcome measures and objective diagnostic tests: now and into the future.
    Curr Opin Pulm Med. 2022 Mar 7. pii: 00063198-900000000-98890.
    PubMed     Abstract available

  7. LECERF K, Prince BT
    Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies.
    Curr Opin Pulm Med. 2022 Mar 7. pii: 00063198-900000000-98889.
    PubMed     Abstract available

  8. SCULLEY JA, Musick H, Krishnan JA
    Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic.
    Curr Opin Pulm Med. 2022;28:93-98.
    PubMed     Abstract available

  9. SINGH D, Mathioudakis AG, Higham A
    Chronic obstructive pulmonary disease and COVID-19: interrelationships.
    Curr Opin Pulm Med. 2022;28:76-83.
    PubMed     Abstract available

  10. WEN J, Milne S, Sin DD
    Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions.
    Curr Opin Pulm Med. 2022;28:152-161.
    PubMed     Abstract available

  11. AGGARWAL AN, Prasad KT, Muthu V
    Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.
    Curr Opin Pulm Med. 2022;28:84-92.
    PubMed     Abstract available

  12. MKOROMBINDO T, Dransfield MT
    Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?
    Curr Opin Pulm Med. 2022;28:109-114.
    PubMed     Abstract available

  13. GOKULAN K, Joshi M, Khare S, Bartter T, et al
    Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2022;28:134-138.
    PubMed     Abstract available

  14. TIEW PY, Mac Aogain M, Chotirmall SH
    The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2022;28:121-133.
    PubMed     Abstract available

  15. KHAN MMKS, Cole AG, Mannino DM
    Precision medicine in chronic obstructive pulmonary disease: how far have we come?
    Curr Opin Pulm Med. 2022;28:115-120.
    PubMed     Abstract available

  16. WANG JM, Han MK, Labaki WW
    Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
    Curr Opin Pulm Med. 2022;28:99-108.
    PubMed     Abstract available

    February 2022
  17. TAN LD, Alismail A, Ariue B
    Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021.
    Curr Opin Pulm Med. 2022 Feb 21. pii: 00063198-900000000-98893.
    PubMed     Abstract available

  18. MUSTAFA SS, Patrawala S, Khurana S
    Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine.
    Curr Opin Pulm Med. 2022 Feb 7. pii: 00063198-900000000-98898.
    PubMed     Abstract available

    November 2021
  19. GARNER JL, Shah PL
    Endobronchial treatment of severe asthma and severe emphysema with hyperinflation.
    Curr Opin Pulm Med. 2021 Nov 1. pii: 00063198-900000000-98914.
    PubMed     Abstract available

    March 2021
  20. MUTHU V, Prasad KT, Sehgal IS, Dhooria S, et al
    Obstructive lung diseases and allergic bronchopulmonary aspergillosis.
    Curr Opin Pulm Med. 2021;27:105-112.
    PubMed     Abstract available

  21. BURKES RM, Panos RJ, Borchers MT
    How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs.
    Curr Opin Pulm Med. 2021;27:120-124.
    PubMed     Abstract available

  22. ALLEN B, Aboussouan LS
    Diagnostic and therapeutic challenges of chronic obstructive pulmonary disease in the elderly.
    Curr Opin Pulm Med. 2021;27:113-119.
    PubMed     Abstract available

  23. LEITAO FILHO FS, Choi L, Sin DD
    Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Curr Opin Pulm Med. 2021;27:125-131.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.